Proteomic survey towards the tissue-specific proteins of mouse mitochondria by Yuan Wang et al.
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2011. This article is published with open access at Springerlink.com life.scichina.com   www.springer.com/scp 
                  
*Corresponding author (email: siqiliu@genomics.org.cn) 
 January 2011  Vol.54  No.1: 3–15 
• RESEARCH  PAPERS • doi: 10.1007/s11427-010-4107-0 
Proteomic survey towards the tissue-specific proteins of mouse 
mitochondria 
WANG Yuan, SUN HaiDan, RU YaWei, YIN SongYue, YIN Liang & LIU SiQi* 
Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 101300, China  
Received June 29, 2010; accepted July 30, 2010 
 
Mitochondrion plays the key functions in mammalian cells. It is believed that mitochondrion exerts the common biologic func-
tions in many tissues, but also performs some specific functions correspondent with tissues where it is localized. To identify 
the tissue-specific mitochondrial proteins, we carried out a systematic survey towards mitochondrial proteins in the tissues of 
C57BL/6J mouse, such as liver, kidney and heart. The mitochondrial proteins were separated by 2DE and identified by 
MALDI-TOF/TOF MS. Total of 87 unique proteins were identified as the tissue-specific ones, and some representatives were 
further verified through ICPL quantification and Western blot. Because these issue-specific proteins are coded from nuclear 
genes, real-time PCR was employed to examine the mRNA status of six typical genes found in the tissues.With combining of 
the expression data and the co-localization images obtained from confocal microscope, we came to the conclusion that the tis-
sue-specifically mitochondrial proteins were widely distributed among the mouse tissues. Our investigation, therefore, indeed 
provides a solid base to further explore the biological significance of the mitochondrial proteins with tissue-orientation. 
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In eukaryotic cells, mitochondria oxidize organic acids via 
the tricarboxylic acid cycle and ATP synthesis as primary 
functions. Mitochondria also have several pivotal roles for 
the maintenance of physiological activities, such as the 
generation of reactive oxygen species, calcium metabolism 
and apoptosis [1,2]. Mitochondrial dysfunction is linked to a 
wide range of human diseases, such as neurodegeneration, 
diabetes, metabolic disorders, tumorigenesis and myopathies 
[3,4]. Mitochondrion is a unique organelle and has its own 
genome (mitochondrial DNA, mtDNA), encoding 13 essen-
tial proteins constituting complexes I, III, IV and V of the 
oxidative phosphorylation system [5]. Approximately 3000 
proteins are estimated to be present in mitochondria, clearly 
indicating that many of these proteins are nuclear-encoded 
and transported into the organelle from extra-mitochondrial 
sources [6].  
Mitochondria in different tissues vary in number, mor-
phology, ultrastructure, respiratory capacity and specific 
metabolic pathways [6]. Most nucleated cells contain 500 to 
2000 mitochondria. For instance, mitochondria make up 
80% of the intracellular volume of the cone cells of eyes, 
60% in the lateral rectus cells and 40% in heart muscle cells. 
In contrast, platelets have only two to six mitochondria per 
cell [7]. A living species genome is relatively stable during 
the life span of the organism, whereas its gene expression 
profiles vary dramatically and are tissue dependent [8,9]. 
Since mitochondrial number is tissue-dependant and most 
their proteins rely on the gene expression status in the re-
sided tissues, a question thus is raised whether a mitochon-
drion in a tissue owns its specific proteome. 
Tissue-specific mitochondrial proteins drew much atten-
tion in the 1980s. Vayssiere et al. [10] adopted 2D electro-
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phoresis (2DE) to separate the mitochondrial proteins from 
the rat brain cortex, muscle and liver, and found the 2DE 
spots distribution was dependent on tissue localization. In 
particular, 16 2DE spots were found exclusively in brain 
mitochondria. Watmough et al. [11] compared mitochon-
drial proteins between normal patients and patients with 
weak muscles, and reported that the abundance of the com-
plex I protein had decreased in the muscles of patients that 
were weak; however no change was observed for the pro-
tein distribution between the two groups for mitochondrial 
proteins isolated from the liver. These early investigations 
did not provide enough information to identify the tis-
sue-specific proteins in mitochondria because of the limited 
analytical approaches. Since the turn of the century, pro-
teomic approaches have expedited protein research, includ-
ing the identification of proteins present in various tissues 
and organelles [12]. Using shotgun tryptic-digestion and LC 
MS/MS, Mann’s group screened mitochondrial proteins 
obtained from the mouse brain, heart, kidney and liver [13]. 
In total, 399 mitochondrial proteins were identified, in 
which approximately 50% were not generally detected in all 
the tissues. This group implemented a quantitative pro-
teomics approach to compare the mitochondrial proteins 
extracted from the rat tissues, heart, liver and skeletal mus-
cle, and observed that approximate one third of the mito-
chondrial proteins identified were predominant to one of the 
three tissues [14]. The largest scale screening for the tis-
sue-specific proteins of cytosol, microsomes, mitochondria 
and nuclei in the mouse brain, heart, kidney, liver, lung and 
placenta was performed using a gel-free multidimensional 
protein identification technology developed by Kislinger et 
al. [15]. Using rigorous statistical filtering and machine-   
learning methods, the subcellular localization of 3274 of the 
4768 proteins identified was determined, including 1503 
previously uncharacterized factors. Proteomics provides 
insight into the tissue-specific expression of mitochondrial 
proteins. However, several issues have not been addressed, 
such as the elucidation of tissue-specific mitochondrial pro-
teins. The survey of mitochondrial proteins in early investi-
gations was based upon LC MS/MS. These studies pre-
sented solid data for peptide separation as well as identifica-
tion; however, evidence for intact protein separation as well 
as identification was missing. Protein identification and 
localization must proceed through a systematic approach 
and involve different approaches to examine cells and tis-
sues. Early analysis of mitochondrial proteins also lacked a 
complete analysis approach. 
Herein, we have extended a systematic survey of the mi-
tochondrial proteomes in the mouse tissues of liver, kidney 
and heart with specific focus on the identification of intact 
proteins present in mitochondria and the quantification of 
the different mitochondrial proteomes from the mouse tis-
sues. The mitochondrial proteins were separated by 2DE 
and identified by MALDI TOF/TOF MS. In total, 87 unique 
proteins were identified as tissue-specific proteins. Some 
mitochondrial proteins were further verified through isotope 
coded protein label (ICPL) quantification and Western blot 
analysis. Because these tissue-specific proteins were from 
nuclear encoded genes, we employed real-time PCR and 
Western blot analysis to examine the status of the distribu-
tion and abundance of six typical genes in the tissues. By 
combining the expression data and the co-localization im-
ages obtained from confocal microscopy, we concluded that 
mitochondrial proteins with tissue-specificity were widely 
distributed among the mouse tissues. Therefore, our inves-
tigation provides a set of data for exploring the biological 
significance of tissue-specific mitochondrial proteins. 
1  Materials and methods 
1.1  Chemicals 
Acrylamide, ammonium persulfate, IPG strips (5 mm×180 
mm or 5 mm×70 mm, pH 3–10 linear), ampholyte pH 3–10, 
urea, CHAPS and all ultrapure reagents for electrophoresis 
were obtained from Bio-Rad (Hercules, CA, USA). All 
chemicals were of analytical grade and were purchased 
from Sigma (St. Louis, MO). Modified porcine trypsin was 
from Promega (Madison, WI). The reagents for cell cultur-
ing were from Sigma (St. Louis, MO). 
1.2  Mitochondria preparation 
Six- to nine-weeks old C57BL6/J male mice were subjected 
to anesthesia by a phenobarbital celiac injection (50 mg kg−1, 
10 mg mL−1) and then perfused with ice-cold saline. The tis-
sues, liver, kidney and heart, were rapidly excised, immersed 
into ice-cold PBS buffer and weighed. The tissues were 
minced and homogenized with a hand-held Dounce homoge-
nizer in the pre-cool homogenization buffer, 220 mmol L−1 
mannitol, 70 mmol L−1 sucrose, 10 mmol L−1 Tris-HCl, pH 
7.4, containing protease and phosphatase inhibitors. Using 
gradient centrifugation, the crude mitochondria were pelleted 
at 8000×g. The crude preparation was further centrifuged 
through a Nycodenz density gradient from 20% to 34% at 
52000×g for 1.5 h. The refined mouse mitochondria were 
enriched upon density fractionation. The integrity and purity 
of the purified mitochondria were assessed by transmission 
electron microscopy (TEM) and western blot analysis using 
mitochondrial specific antibodies, ATP synthase β (BD Bio-
sciences, CA), prohibitin, aldehyde dehydrogenase II (Santa 
Cruz, CA) as well as antibodies directed against the cyto-
plasm and a cytoplasm specific antibody, aldehyde reductase 
and GAPDH, were purchased from Santa Cruz, CA. The pu-
rified mitochondria were stored at −80°C.  
1.3  2DE 
The harvested mitochondria were washed three times using 
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washing buffer (50:50:0.1 volumes of ethanol:acetone: 
acetic acid) and subsequently lysed with lysis buffer con-
taining 7 mol L−1 urea, 2 mol L−1 thiourea, 4% (w/v) 
CHAPS, 10 mmol L−1 DTT, 1 mmol L−1 PMSF and 2 mmol 
L−1 EDTA. The lysed mitochondria were sonicated with a 
probe sonicator for 5 min followed by centrifugation at 
35000×g for 30 min. After quantification of the proteins 
using the Lowry assay, the supernatants were used for elec-
trophoresis. Approximate 100 μg protein was loaded for 
2DE analysis. Isoelectric focusing was carried out using 18 
cm, pH 3–10 L IPG strips and run at 70 kVh and 0.05 
mA/strip at room temperature. After reduction using 1% 
DTT for 15 min and alkylation using 2.5% IAM for 15 min, 
the second-dimension SDS-PAGE was conducted in 18 cm 
12% acrylamide gels at 15 W/gel until the dye front reached 
the bottom of the gels.  
The 2DE gels were stained using silver nitrate with a 
modified protocol. All the silver-stained gels were scanned 
by a laser densitometer at 500 pixel resolution (Powerlook 
2100XL, UMAX, Dallas, TX). The gel images were ana-
lyzed with Imagemaster Platinum version 5.0 (GE Health-
care, Fairfield, CT). The threshold defined as the significant 
change in spot volume was 3-fold at least upon the com-
parison of the average gels between liver, kidney and heart. 
The final spot volumes were statistically determined using 
three mitochondrial preparations as well as duplication runs.  
1.4  Protein identification with mass spectrometry 
The differential 2DE spots were manually excised and diced 
into small pieces (<1 mm). The proteins were digested with 
0.025 mg mL−1 trypsin in 25 mmol L−1 NH4HCO3 and in-
cubated at 37°C for 16 h. Only 1 μg of the supernatant from 
the in-gel digestions was loaded onto the Anchorchip target 
(Bruker Dalton, Bremen, Germany) and allowed to dry 
completely. Then 0.8 μL of the matrix solution (CHCA, 1:1, 
v/v) was added to the target and mixed with the digested 
peptides. After washing with 0.5% TCA, the Anchorchips 
were delivered to the MALDI TOF/TOF mass spectrometry 
(MS) for protein identification. Positively charged ions were 
analyzed in the reflector mode, using delayed extraction. 
Typically 100 shots were accumulated per spectrum in the 
MS mode and 400 shots in the MS/MS mode. The spectra 
were processed using the FlexAnalysis 2.2 and BioTools 2.2 
software tools. 
Based upon mass signals, protein identification was per-
formed using the Mascot software (http://www.matrix-      
science.com) to search the NCBI’s nr database using the 
mouse taxonomy. The following parameters were used for 
database searches: monoisotopic mass accuracy <0.01%, 
missed cleavages 1, carbamidomethylation of cysteine as a 
fixed modification, oxidation of methionine, N-terminal 
pyroglutamylation (peptide) and N-terminal acetylation 
(protein) as variable modifications. In the MS/MS mode, the 
fragment ion mass accuracy was set to <0.7 Da. 
1.5  Quantitative proteomics using an ICPL 
The ICPL strategy was performed using the instruction 
manual from SERVA (SERVA Electrophoresis, Heidelberg, 
Germany). The protein samples were chemically derivatized 
to two distinguishable isotopic forms (light, nondeuterated, 
12C and heavy, deuterated, 13C). Equal aliquots of the two 
differentially labeled samples were mixed and separated by 
2DE. Protein quantification was automatically calculated by 
the relative abundance of light and heavy ICPL-labeled 
peptides using the Peakpicker software (Applied Biosys-
tems, USA).  
1.6  Western blot analysis 
Equal amount proteins (10 μg/lane) of each sample were 
loaded onto a 12% SDS-PAGE and electro-transferred to 
polyvinylidene difluoride (PVDF) membranes (350 mA, 1 h) 
using a Bio-Rad Mini PROTEAN 3 system (Hercules, CA, 
USA) according to the standard protocol. The PVDF mem-
branes were blocked with TBS containing 5% nonfat milk 
powder and 0.1% Tween 20 at 4°C overnight, and incubated 
with the individual antibodies as primary ones, such as 
anti-SCP2, anti-HADHB, anti-SCOT were generated from 
our laboratory by immunization of rabbits with the purified 
SCOT and HADHB recombinant protein, anti-aldehyde 
dehydrogenase II, anti-prohibitin, anti-aldehyde reductase, 
anti-catalase (The Binding Site Inc. USA), anti-PDZK 1, 
anti-sMtCK, anti-GAPDH (Santa Cruz Biotechonolgy, 
USA), and anti-ATP synthase β (BD Biosciences, USA). 
The appropriate secondary antibody conjugated with horse 
radish peroxidase (HRP) was used to visualize the primary 
immune-recognitions using the ECL kit (Amersham Phar-
macia Biotech, Uppsala, Sweden). 
1.7  Quantitative real-time RT-PCR 
Quantification of gene expression for SCP2, PDZK1, 
sMtCK, catalase, SCOT and HADHB was performed via 
real-time RT-PCR using an ABIPRISM 7300 system (Ap-
plied Biosystems, Foster City, CA). The cDNA libraries 
were generated from the total RNA preparations performed 
using the isolated mouse liver, kidney and heart tissues. The 
primers were designed to span the exon-intron junctions of 
these genes as follows, SCP2: 5′-TGCCTTCAAAGTG- 
AAAGATGGCCC-3′ (forward) and 5′-TTCCCTTGAAA- 
GAAGGCCGACTGA-3′ (reverse); PDZK1: 5′-AGGCAG- 
CTGGCTTGAAGAACAATG-3′ (forward) and 5′-AAAG- 
AAGTGGAGAGAACCGAGCCA-3′ (reverse); sMtCK: 5′- 
TAAGATCTTGGAGAACCTGCGGCT-3′ (forward) and 
5′-TCTTGGCCTCTCTCCAGCTTCTTT-3′ (reverse); cata-   
lase: 5′-TGCAGATACCTGTGAACTGTCCCT-3′ (forward) 
and 5′-AAGCGTTTCACATCTACAGCGCAC-3′ (reverse); 
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SCOT: 5′-GCTCTGGTGAAAGCATGGAAAGCA-3′ (for-    
ward) and 5′-TCCCTTTATGAGGCGGTGCACATA-3′ (re-   
verse); HADHB: 5′-CACTTTCGGGTTTGTTGCATCGGA- 
3′ (forward) and 5′-GCTGTGGTCATGGCTTGGTTTG- 
AA-3′ (reverse).  
Each sample was normalized on the basis of GAPDH 
expression. Data were analyzed according to the relative 
gene expression using the 2−ΔΔCt method. Moreover, melting 
curves for each PCR reaction were analyzed carefully to 
confirm the purity of the amplification product. 
1.8  Confocal experiments 
Three cell lines derived from normal tissues were adopted 
for the confocal experiments: the Chang cell line for the 
liver (a gift from Dr. Liu YinKun, Fudan University), the 
MC cell line for the kidney (a gift from Dr. Guan YouFei, 
Peking University) and the H9C2 cell line for the heart 
(ATCC, Rockville, MD). The three cell lines were seeded 
into humidified chambers and cultured for 24 h. Subse-
quently, the cells were incubated with diluted MitoTracker 
Red (Invitrogen, Eugene, USA) for 30 min and fixed with 
3.7% formaldehyde for 15 min. The antibodies against spe-
cific proteins were used as the primary antibodies and incu-
bated with the fixed cells for 2 h. Following thorough 
washing of the material with 0.05% Triton X-100 in PBS, 
the treated cells were incubated with the FITC-conjugated 
goat immunoglobulins against rabbit IgG contained in 1% 
BSA PBS for 1 h. The fluorescent images were acquired 
using a confocal laser scanning microscope, Zeiss LSM510 
(Carl Zeiss MicroImaging, Aalen, Germany). For referenc-
ing organelle localization, DAPI was used to stain the nu-
clei.  
2  Results 
2.1  Analysis of 2DE images from the mitochondria of 
different mouse tissues 
To ensure the quality of mitochondrial preparation from 
mouse tissues, the prepared mitochondria were examined by 
western blot and TEM analyses. With three specific anti-
bodies against mitochondrial proteins in the western blot 
analysis, ATP synthase β, aldehyde dehydrogenase II and 
Prohibitin, the unique immuno-recognized bands appeared 
in the three preparations of mitochondria; however, these 
bands were not observed in the cytoplasm fractions (Sup-
plemental Figure 1A). The TEM images for the mitochon-
drial preparations revealed that the ratios of intact mito-
chondria were >90% (Supplemental Figure 1B). The mito-
chondrial proteins were resolved by 2DE as shown in Fig-
ure 1A. To avoid experimental errors generated by 2DE 
operations and individual variations among mice, the mito-
chondria were individually prepared from six mice, and 
each mitochondrial preparation was duplicated in the 2DE 
analysis. For each tissue, the 2DE images were statistically 
analyzed on the basis of the six samples. On average, there 
were 754±35 (n=6) 2DE spots identified for the heart mito-
chondria, 1018±47 (n=6) 2DE spots were identified for the 
kidney mitochondria and 1039±46 (n=6) 2DE spots were 
identified for the liver analysis. The overlapping rates of the 
2DE spots for the parallel preparations and runs were ap-
proximate 90%. As shown in Figure 1A, the 2DE patterns 
are clearly different between the individual tissues. The 
total number of 2DE spots from the heart mitochondria 
samples was almost 30% less than the other two tissues. 
The number of 2DE spots located within the higher pI side 
for the heart mitochondria were significantly more than that 
of the mitochondrial proteins observed for both the liver and 
kidney samples. Moreover, mouse liver and kidney mito-
chondria were comparable with overlapping rates of ap-
proximately 80%. To identify 2DE spots specifically lo-
cated in a certain mitochondrial preparation, comparison of 
the 2DE images was initially conducted between any two 
tissue mitochondria, i.e., liver vs. heart, heart vs. kidney and 
kidney vs. liver, and then these spots with infinite change in 
spot volume were further confirmed by comparison with the 
third tissue. A total of 134 tissue-specific 2DE spots were 
defined; 26 as liver specific, 18 as kidney specific and 10 as 
heart specific. Moreover, 6 2DE spots were identified in 
both heart and liver but not in kidney, 19 were shared with 
heart and kidney but not in liver, and 55 were shared with 
liver and kidney but were not observed for the heart samples. 
The localized comparison of 2DE images for several tissue 
specific spots is presented in Figure 1B. 
2.2  Identification of tissue-specific mitochondrial pro-
teins by MALDI TOF/TOF MS 
The 134 different 2DE spots were in-gel tryptic digested 
and delivered to MALDI-TOF/TOF MS. Of the 87 spots 
identified as proteins, 20 were liver specific, such as SCP2, 
14 were kidney specific, such as PDZK1, and six were heart 
specific, such as sMtCK. Five proteins were shared by heart 
and liver, but not by kidney such as HADHB, eight were 
shared by heart and kidney but not by liver, such as SCOT, 
and 34 were shared by liver and kidney but not by heart, 
such as catalase. Figure 1C shows a typical MALDI-TOF/     
TOF mass spectrogram, indicating that PDZK1 is present. 
The identification summary based upon mass spectrometry 
analysis is presented in Table 1.  
According to the Gene Ontology (GO) analysis, the 87 
identified proteins were divided into five categories based on 
biological functions. Of these proteins, 24 were related with 
energy metabolism, eight with apoptosis, 17 with mainte-
nance of ionic homeostasis, 28 with oxidative phosphoryla-
tion, and 10 with other functions. Basing the GO analysis on 
subcellular locations, 52 proteins were predicted as mito-
chondrial located, seven as part of an endomembrane system  
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Figure 1  2DE images of the mitochondrial proteins from mouse liver, kidney and heart and the protein identification by MALDI TOF/TOF MS. A, The 
2DE images of the mitochondrial proteins extracted from mouse liver (LM), kidney (KM) and heart (HM). B, The typically close-up analysis of the 2DE 
images for the tissue-specific spots. Spots labeled with a, d, and e were specific to liver, heart and kidney, respectively. The spot labeled with b is shared by 
liver and kidney but was not observed in heart samples; the spot labeled c is shared by kidney and heart not by the liver; the spot marked f was found in the 
liver and heart samples but was not observed in the kidney samples. C, The spectra of MALDI TOF/TOF MS and MS/MS for the identification of PDZK1. 
Upon the PMF signals, the parent ions 1119.501 and 1391.563 were selected for MS/MS analysis, which led to two peptides with amino acid sequences  
derived from the sequence of PDZK1 as LFAYPDTHR and NFTDVHPDYGAR. 
(including endoplasmic reticulum, peroxisome, and micro-
some) and 28 were non-specific subcellular localized. Of 
the 87 unique tissue-specific mitochondrial proteins in our 
list, 12 are also documented in the report by Mann. 
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Liver-specific mitochondrial proteins 
1 gi|45476581 Sterol carrier protein 2 (SCP2) 59715/63920 8.00/8.06 32 MGFPEAASSFR 
2 gi|6754156 Hydroxyacid oxidase 1, liver 41260/42467 7.60/7.92 63 NVADIDLSTSVLGQR 
3 gi|477004 Epoxide hydrolase 63117/62399 5.85/6.23 72 YQIPALAQAGFR 
4 gi|74200069 Calregulin 42341/64342 4.57/6.21 70 
IKDPDAAKPEDWDER 
ILFIFIDSDHTDNQR 
5 gi|127526 Major urinary protein 1 precursor 20920/20587 5.02/4.52 48  
6 gi|18044669 Urate oxidase 35245/35482 8.48/8.32 32 AHVYVEEVPWKR 
7 gi|6678085 Serine proteinase inhibitor 46140/51913 5.24/5.30 23  
8 gi|23396871 Small ubiquitin-related modifier3 12593/53764 5.25/5.39 35  
9 gi|18044557 Peroxiredoxin 4 31261/29939 6.57/6.28 48  
10 gi|13879360 Cathepsin B precursor 38168/26073 5.57/5.27 27 SGVYKHEAGDMMGGHAIR 
11 gi|47682713 Nudix-type motif 7 27068/31324 5.90/6.16 16 FGLGPEPPR 
12 gi|30354044 Insulin-like growth factor 2 63681/23537 9.31/5.84 10  
13 gi|50299 Cathepsin D 44742/31129 6.71/5.92 23 
NYELHPDKYILK 
NIFSFYLNR 
14 gi|2624496 Glutathione S-transferase P 1 23521/24501 8.13/7.76 36 
PPYTIVYFPVR 
FEDGDLTLYQSNAILR 
15 gi|226471 Superoxide dismutase [Cu-Zn] 15923/17653 9.03/6.31 43  
16 gi|19353248 Hydroxymethylgulataryl-CoA synthase 57300/49579 8.65/7.93 30 TKLPWDAVGR 
17 gi|33859506 Albumin 1 70730/75458 5.75/5.75-6.02 37 LGEYGFQNAILVR 
18 gi|56789381 Acidic ribosomal phosphoprotein P0 34366/36764 5.91/5.87 65  
19 gi|13384700 Endoplasmic reticulum protein ERp19 19208/19577 5.14/5.10 47  
20 gi|193446 Vitamin D-binding protein 54647/56333 5.62/5.17 35 
SLSLILYSR 
RTQVPEVFLSK 
Kidney-specific mitochondrial proteins  
21 gi|32363497 Cytovillin 69347/70826 6.28/6.31 35  
22 gi|2827776 Endopeptidase-2 85227/84967 6.00/5.24-5.76 23 VGVYDKDCDCFR 




24 gi|5305216 Glutathione peroxidase 22553/24680 6.54/5.98 23  
25 gi|2494732 Gamma-glutamyltranspeptidase 1 61866/24708 7.00/6.81 15 
ASGGWAAASDSR 
DIDQVVTAGLK 
26 gi|6755963 Voltage-dependent anion channel 1 30891/34360 9.00/7.96 48 LVAAKCTLAAR 
27 gi|2058343 V-ATPase B2 subunit 56948/58414 6.00/5.38 29  
28 gi|13626101 Alpha-methylacyl-CoA racemase 39854/40560 7.00/7.61 36  
29 gi|220396 D-amino-acid oxidase 38970/39636 7.00/7.42 41 SYLPWLTER 
30 gi|125957 Lamin B2 67103/68540 7.32/7.60 42  
31 gi|20336740 Ret finger protein-like 4 33079/32203 8.00/7.78 20  
32 gi|3114602 
Phospholipid hydroperoxide glutathione 
peroxidase 
22794/19826 8.74/8.28 28  
33 gi|15617203 Chloride intracellular channel 1 27338/30537 5.09/4.97 48  
34 gi|14874758 Peroxiredoxin 2 21936/22347 5.20/4.62 32  
Heart-specific mitochondrial proteins  
35 gi|38259206 
Creatine kinase, mitochondrial 2 
(sMtCK) 
47899/45112 8.64/8.25 59 ITHGQFDER 
36 gi|18700024 Isocitrate dehydrogenase 3 42453/41763 8.76/7.33 46 HNNLDLVIIR 




Myosin regulatory light chain 2, ven-
tricular/cardiac muscle isoform 
18870/19893 4.71/4.76 81 DGFIDKNDLR 
39 gi|3806019 Ubiquinone biosynthesis protein coq7 20228/19893 5.52/6.04 27  
40 gi|160151263 
Dihydrolipoyllysine-residue succinyl-
transferase component of 
2-oxoglutarate dehydrogenase complex 
49306/42289 5.70/5.96 22  
Proteins shared by the liver and kidney mitochondria that are not found in heart mitochondria  
41 gi|15488606 catalase 60013/60913 7.72/7.30-8.27 16 LFAYPDTHR 
(To be continued on the next page) 
















42 gi|74211686 Protein disulfide-isomerase precursor 56965/57688 4.79/4.29 58 
VDATEESDLAQQYGVR 
ILFIFIDSDHTDNQR 
43 gi|118542 Glutamate dehydrogenase 1 61640/56356 8.05/7.61 52 
DDGSWEVIEGYR 
HGGTIPVVPTAEFQDR 
44 gi|31981722 Heat shock 70 kD protein 5 72492/72954 5.09/4.89 50 
IINEPTAAAIAYGLDKR 
VTHAVVTVPAYFNDAQR 
45 gi|61402231 Glutathione S-transferase, mu 1 26067/26486 7.71/7.81 72  
46 gi|54673814 Enolase 1, alpha non-neuron 47453/51686 6.37/6.73 60  
47 gi|29839593 
Thioredoxin domain containing protein 
5 
47070/49147 5.51/5.31 33 
GYPTLLLFR 
GYPTLLWFR 
48 gi|133284 Testosterone-regulated RP2 protein 40799/42556 6.22/6.57 16 FGLGPEPPR 
49 gi|63663965 Helix-destabilizing protein 41673/41724 5.00/6.31 26  
50 gi|19353187 Otc protein 39511/39489 8.81/8.40 49 KPEEVDDEVFYSPR 
51 gi|6677739 Regucalcin 33899/32757 5.15/4.94 40  
52 gi|18043606 Gpd1 protein 38176/35262 6.75/7.22 40  
53 gi|22122515 AHA1 38321/35408 5.41/5.81 26  
54 gi|13542901 Thiosulfate sulfurtransferase 33673/35629 7.71/8.32 48 
FQLVDSR 
VLDASWYSPGTR 




Noyl Coenzyme A hydratase domain 
containing 2 
26449/30281 7.68/7.41 30  
57 gi|25452978 Hydroxyacylglutathione hydrolase 29168/31547 9.00/8.12 27  
58 gi|73622214 Putative L-aspartate dehydrogenase 30479/32619 6.45/7.01 55 
GLCPLAPR 
WGHTVFVAR 
59 gi|6671549 Peroxiredoxin 6 24925/26939 5.98/6.55 30  




Vitamin K epoxide reductase complex 
subunit 1-like protein 1 




27516/29582 8.53/9.19 32  
63 gi|30580818 
AMP phosphotransferase mitochondrial 
AK3 
21237/22895 8.57/9.02 53 TVGIDDLTGEPLIQR 
64 gi|14602583 Glutathione transferase, alpha 3 25401/26801 8.76/9.24 21 
NRYFPAFEK 
SHGQDYLVGNR 
65 gi|71051228 Peptidyl-prolyl cis-trans isomerase A 18131/17803 7.74/7.76 40 SIYGEKFEDENFILK 




43295/40342 9.00/8.79 43 QNLTQDLFR 
68 gi|27527044 Akr7a5 protein 38109/38875 6.00/6.81 31 FFGNNWAETYR 
69 gi|13124286 Hydroxyacid oxidase 3 39145/39156 9.00/8.16 20 SVAEISPDLIQFSR 




32675/35730 8.00/8.57 20  
72 gi|82952043 
Fumarylacetoacetate hydrolase domain 
containing protein 1 
25484/30270 5.00/6.72 22  
73 gi|9903607 Transmembrane protein 4 21096/18375 4.95/4.95 62  
74 gi|30525896 3-ketoacyl-CoA thiolase B  8.82/7.97 35  
Proteins shared by the liver and heart mitochondria that are not found in kidney mitochondria 
75 gi|17933768 Glyoxylate reductase 35706/37180 7.57/7.71 29  
76 gi|15488707 
Acetyl-Coenzyme A dehydrogenase, 
medium chain 
46908/43000 8.60/8.04 35 IYQIYEGTAQIQR 
77 gi|54887356 Trifunctional protein, alpha subunit 83302/80884 9.24/9.44 30 LPAKPEVSSDEDVQYR 




Trifunctional enzyme beta subunit 
(HADHB) 
51639/50864 9.43/9.56 51 NIVVVEGVR 
Proteins shared by the kidney and heart mitochondria that are not found in liver mitochondria 
80 gi|18266680 3-oxoacid CoA transferase 1 (SCOT) 56352/58122 8.73/7.62 42 
LIKGEKYEKR 
SKQIKR 
81 gi|10129957 Peroxiredoxin 5 17175/16255 7.71/8.37 61 GGAKTLMNTIMQLR 
(To be continued on the next page) 
















82 gi|31542559 Dihydrolipoamide S-acetyltransferase 59389/58150 5.71/5.83 36 VPEANSSWMDTVIR 
83 gi|29612662 
AU RNA-binding enoyl-coenzyme A 
hydratase 
33602/33764 9.49/9.25 14  
84 Q9CQ62 2, 4-dienoyl-CoA reductase 36476/33076 9.00/9.06 13  
85 gi|20455479 Atp5b protein 56632/29416 5.00/6.14 24 AHGGYSVFAGVGER 
86 gi|29436756 Nuclear mitotic apparatus protein 1 236599/29753 5.68/5.83 10  
87 gi|6753530 Crystallin, alpha B 20056/22708 7.71/7.36 48 QDEHGFISR 
 
2.3  Further identification of the tissue-specific mito-
chondrial proteins using an ICPL approach 
Although 2DE images provide the solid evidence that the 
mouse tissues have specific mitochondrial proteins, the im-
age analysis approach is semi-quantitative. We thus adopted 
stable-isotope labeling to further verify the differential quan-
tification of the 2DE spots. As described in Materials and 
methods, the mitochondrial proteins from three tissues were 
labeled with 12C or 13C, and the paired samples were mixed 
with equal amounts of proteins, such as heart/kidney, 
heart/liver and kidney/liver. These samples were applied to 
2DE. The 2DE images with labeled proteins are shown in 
Figure 2A, in which all the 2DE spots exhibit an acidic-shift, 
indicating that the mitochondrial proteins have been suc-
cessfully labeled with ICPL. A typical quantitative determi-
nation based on the MALDI TOF/TOF MS mass spectro-
grams is presented in Figures 2B. This example indicates 
that SCOT is identified in the mixture of mitochondrial sam-
ples from heart and kidney with relative average abundances 
of 2.9:1 (H:K). The relative abundances of several different 
proteins identified are summarized in Table 2. Clearly, the 
conclusions drawn from ICPL quantification are in agree-
ment with the 2DE image analysis results. 
2.4  Verification of the tissue-specific localization of 
mitochondrial proteins by Western blot analysis 
By carefully selecting antibodies which represent tissue-    
specificity, we implemented Western blot analysis to verify 
the proteomic results. As summarized in Table 1, SCP2 is 
specifically localized in the liver mitochondria, PDZK1 
only in the kidney mitochondria, and sMtCK only in the 
heart mitochondria. HADHB is shared by the heart and liver 
mitochondria but is not found in those of the kidney, 
whereas SCOT is shared by the heart and kidney but is not 
found in the liver, and catalase is shared by the liver and 
kidney but is not found in the heart. As shown in Figure 3, 
the image data of the western blot analysis supports the 
conclusions derived from the proteomic observations. 
2.5  Comparison of the gene expression status for the 
tissue-specific mitochondrial proteins in three tissues 
All the tissue-specifically mitochondrial proteins were iden-
tified to be nucleus-encoded. These proteins are synthesized 
and packaged outside of the mitochondria, and then enter 
mitochondria through a mitochondrial transporter. Because 
the proteins are specifically localized in the tissue mito-
chondria, a question is raised about whether the transcrip-
tion of these proteins is also tissue specific.  
We selected six tissue-specific mitochondrial proteins, 
sMtCK, SCP2, PDZK1, catalase, SCOT and HADHB, and 
examined their gene expression status in the three tissues 
using real-time RT-PCR. The quantitative data of RT-PCR, 
presented in Figure 4 with GAPDH as an internal control, 
revealed that the mRNA tissue-distributions for sMtCK, 
catalase, SCP2 and SCOT genes are similar to their proteins 
in terms of the tissue-specific mitochondrial location. 
However, PDZK1 and HADHB are widely expressed 
through all three tissues. The results prompted us to pursue 
another question on whether the status of protein expression 
is tissue-specific. 
We used the six antibodies against sMtCK, SCP2, 
PDZK1, catalase, SCOT or HADHB in Western blot analy-
ses to identify their protein abundances in mitochondria, the 
cytoplasm or whole tissue. As presented in Figure 3, the 
tissue specificity of sMtCK, catalase, SCP2, and SCOT in 
the cytoplasm and whole tissue is similar to their mitochon-
drial location, whereas the PDZK1 and HADHB levels in 
the cytoplasm and whole tissue is different from their dis-
tribution in the tissue-specific mitochondria. The PDZK1 
protein is only detected in the kidney mitochondria, whereas 
this protein was found in the cytoplasm of the three tissues. 
The HADHB protein is detected in the liver and heart mi-
tochondria but is not detected in those of the kidney, 
whereas this protein was found in all three tissues either in 
the cytoplasm or in the tissue extraction, even though the 
abundant distribution is still tissue-dependent. Taken to-
gether, the transcription and translation level for the tis-
sue-specific mitochondrial proteins is likely to be consis-
tently distributed in the three tissues.  
2.6  Detection of the tissue-specific mitochondrial pro-
teins in vivo  
Three cell lines, Chang, MC, and H9c2, which represent the 
predominant cells found in the liver, kidney and heart, 
respectively, were selected and the subcellular distribution 
of the tissue-specific mitochondrial proteins were monitored  
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Figure 2  Quantification of the tissue-specific mitochondrial proteins by the ICPL method. A, Typical 2DE images for the heart mitochondrial proteins that 
are 12C-labeled and mixed with the kidney mitochondrial proteins which are 13C-labeled. B, The mass spectrum of PMF for SCOT labeled with ICPL for the 
mixture of heart and kidney mitochondrial proteins. Three peptide pairs 969.535/981.572, 1578.794/1596.849 and 2091.955/2116.040 were selected for the  
quantification calculation. The intensity ratios are illustrated in the insets. 
Table 2  Quantification of the tissue-specific mitochondrial proteins by the ICPL methoda) 
Protein name Description 
Mix gel name 
of the identified pro-
teins 
Identified peptide with ICPL Spectrum Distance Area ratio 
Catalase 
Expressed in liver 
and kidney mito-
chondria, not in heart 












Expressed in kidney 
and heart mitochon-
dria, not in liver 




























Expressed in liver 
and heart mitochon-
dria, not in kidney 
Identified in H/K, K/L, 
not detected in H/L 
K:L 
LSLLSKFR 
1068.621/1074.642 6 0.089 
a) L, K, H represent liver, kidney and heart mitochondria, respectively. K:L, H:K, H:L represent the image of two mitochondrial protein mixtures of two 
mouse tissues using 12C/13C labeling. 
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Figure 3  Analysis of Western blot results for six proteins that reside in the cytoplasm, mitochondria and tissue lysates of mouse liver, kidney and heart. The 
labels, LM, KM, HM, LC, KC, HC, LT, KT and HT, where L, K and H represent liver, kidney, heart and M, C and T represent mitochondria, cytoplasm and  
tissue lysate. The antibody against ATP synthase β was used as a reference mitochondrial protein. 
 
Figure 4  mRNA abundance of sMtCK, PDZK1, SCP2, catalase, SCOT, and HADHB in mouse liver, kidney and heart measured by quantitative real-time 
RT-PCR. The Ct values were normalized by the Ct value of GAPDH. The relative mRNA abundances were derived from the 2−ΔΔCt method. 
in vivo. Representative images of the confocal microscopy 
are present in Figure 5, in which the tissue-specific mito-
chondrial proteins are recognized by the corresponding an-
tibodies and mitochondria are labeled by MitoTracker Red. 
On the left panel of Figure 5, sMtCK, PDZK1 and SCP2 are 
specifically located in the cellular mitochondria, heart, kid-
ney and liver, respectively, and the antibody signals pre-
cisely match with the mitochondrial indicator. On the right 
panel of Figure 5, catalase is present in the liver and kidney 
cellular mitochondria but not in those of the heart cells; 
SCOT was observed to be present in the heart and kidney 
cellular mitochondria, but was not present in those of the 
liver cells; and HADHB was present in the heart and liver 
cellular mitochondria, but not in those of the kidney cells. 
All the co-localization evidences of the antibodies and Mi-
toTracker acquired from the in vivo study are in agreement  
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Figure 5  Confocal images for the tissue-specific mitochondrial proteins. 
The images of confocal microscopy for three cell lines, Chang, MC and 
H9c2 using six antibodies, sMtCK, PDZK1, SCP2, catalase, SCOT and 
HADHB, as the primary antibodies. Mitotracker was used as the mitochon- 
drial indictor and IgG conjugated with FITC as the secondary antibody. 
with the conclusions drawn from the proteomic and im-
muno-blot observations. Moreover, the confocal data dem-
onstrated that the organelle distribution of the tissue-spe-      
cific mitochondrial proteins in cells is similar to their or-
ganelle distribution in tissues. 
3  Discussion 
Tissue-specific mitochondrial proteins have been docu-
mented by several laboratories; however, most early reports 
did not focus on the issue of whether the tissue-specific or-
ganelle is a common phenomenon found in nature. Mann’s 
group initiated the proteomic investigation towards differ-
ential expression of proteins in tissues using LC MS/MS and 
found several tissue-specific mitochondrial proteins [13,14]; 
however, their major focus was to establish the methodol-
ogy instead of the biological significance. In this study, our 
goal differs from other studies. For the first time, we clearly 
state that the objective is to systematically scrutinize the 
tissue-specific mitochondrial proteome and elucidate the 
natural phenomenon of protein distributions associated with 
tissues as well as organelles. For this systematic study to be 
successful, we have implemented a set of experiments based 
on the following considerations. First, the core data for dis-
covery of the tissue-specific protein expression levels in-
volves the quantitative comparison of the mitochondrial 
proteome in different tissues. Multiple quantifications of 
proteins were thus employed in this project. Secondly, since 
most mitochondrial proteins are encoded by nuclear genes, 
a mitochondrial protein may also exist outside the mito-
chondrion. Therefore, subcellular localization of the protein 
should be carefully evaluated with respect to the abundance 
of the protein inside and outside mitochondria. To define 
the correlation between transcription and translation, the 
determination of mRNA and protein for a tissue-specific 
mitochondrial protein is likely to provide further information. 
Third, most investigations in this field have only focused on 
differential proteomics in tissues. This approach cannot 
avoid some misinterpretations from the tissue proteomics 
due to the abundance of proteins contributed from multiple 
cells. The proteomic survey based upon the comparison of 
tissue and cell proteomes is therefore expected to offer more 
convincing evidence.  
A total of 87 tissue-specific mitochondrial proteins were 
identified in this study. Approximate 60% of these proteins 
are reported in literature or found in the MITOP2 database. 
Additionally, some proteins were found to be localized both 
in the mitochondria and other subcellular organelles. For 
instance, 3-ketoacyl-CoA thiolase A and testosterone-regu-      
lated RP2 may be localized to both mitochondria and the 
peroxisome, while aldehyde dehydrogenase 3 may be local-
ized to both mitochondria and the endoplasmic reticulum. 
Importantly, 10% of these mitochondrial proteins have not 
been previously reported as mitochondrial proteins, such as 
PDZK1, Glutathione S-transferase mu1 and P1. Further-
more, careful comparison of data with Mann’s report was 
also performed. Of the 87 unique tissue-specific mitochon-
drial proteins found, 12 have also been documented in this 
report, including three in the liver; sterol carrier protein 2, 
glutathione S-transferase P1 and hydroxymethylglutaryl-     
CoA synthase, one in the heart; sarcomeric mitochondrial 
creatine kinase, seven shared by the liver and kidney; glu-
tamate dehydrogenase 1, glutathione S-transferase mu1, 
2,3-hydroxyacyl-CoA dehydrogenase II, glutathione trans-
ferase, alpha3, 3-hydroxyisobutyryl-coenzyme A hydrolase 
and hydroxyacid oxidase 3, and two shared by the liver and 
heart; acetyl-coenzyme A dehydrogenase and the trifunc-
tional enzyme beta subunit. However, the remaining 75 
proteins were not listed in the results of Mann’s group as 
mitochondrial proteins. These results demonstrate that the 
two approaches to protein identification, peptides separated 
by HPLC and intact proteins separated by 2DE, have some 
special separate features that are not congruent. Therefore, 
our data complements other investigations that have used 
different approaches to examine mitochondrial proteins.  
To further explore the tissue-specific mitochondrial pro-
teins, we selected six proteins, sMtCK, SCP2, PDZK1, 
catalase, SCOT and HADHB, and examined their organelle 
localization through multiple approaches. Our selection of 
the mitochondrial biomarkers came from three criteria, (i) 
some proteins are well documented mitochondrial proteins, 
(ii) some have only been identified in this study, and (iii) 
technically they are measurable by the approaches em-
ployed. 
sMtCK is a sarcomeric mitochondrial creatine kinase that 
catalyzes phosphoryl transfer reactions between creatine 
and ATP. This protein was found in higher abundance in 
heart mitochondria when compared with the other two tis-
sues examined. This observation is not surprising because 
the presence of the sarcomere is unique in muscle and heart 
tissues [16,17]. The data is also in agreement with the report 
from Mann’s group [13]. Comparison of the SCP2 abun-
dance in three mitochondria, it was found higher level in 
liver. SCP2 functions in the regulation of cholesterol me-
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tabolism and transportation, and the synthesis of steroid 
hormones [18]. Because the synthesis of cholesterol occurs 
in the peroxisome and the cytosolic portion of the endo-
plasmic reticulum, whereas the synthesis of steroid hor-
mones occurs in mitochondria, SCP2 is highly expressed in 
organs involved in lipid metabolism, and therefore expected 
to have different subcellular localizations [19,20]. Using the 
immunofluorescence EM technique, Keller et al. [21] found 
that SCP2 was localized to the mitochondria, peroxisome, 
and endoplasmic reticulum in rat liver tissue. Moncecchi et 
al. [22] proposed that the multiple subcellular localization 
of SCP2 may be due to SCP2 isomers that are generated by 
different RNA transcription, editing and post-translational 
modification processes. Our data acquired from 2DE, west-
ern blot and real-time PCR matches with the theoretical 
expectation as well as previous reports: the SCP2 gene is 
primarily expressed in the liver. Although the results of the 
confocal analysis indicate that SCP2 is localized in mito-
chondria, our data cannot exclude the possibility that SCP2 
is localized in other organelle due to the lack of evidence 
obtained from the specific indicators for other organelles. 
PDZK1 is mainly responsible for the regulation of Na+/H+ 
exchange so that this protein is highly expressed in kidney 
tissue, such as the surface of the renal tubular epithelial 
cells [23–26]. The subcellular localization of PDZK1 has 
not been reported yet. In our data, the gene expression of 
PDZK1 was detectable in mouse liver, kidney and heart, by 
real-time PCR or by protein identification. Interestingly, 
PDZK1 was only found in the kidney mitochondria but not 
in those of the other two tissues, whereas this protein was 
detected in the cytoplasm of all three tissues. The specific 
localization of PDZK1 in the kidney mitochondria evokes a 
hypothesis that PDZK1 is likely to have dual functions 
which are determined based on the specific cellular location 
of the protein. 
Catalase is one of the major antioxidases in organisms, 
and widely expressed in many mammalian tissues. Gener-
ally, catalase is believed to be localized in the peroxisome 
and cytosol. With quantitatively proteomic approaches, Ji-
ang et al. [27] claimed that catalase was localized to rat 
liver mitochondria. Our data supports this observation and 
further extends the previous analysis on this protein to indi-
cate that catalase is present in liver and kidney mitochondria 
but not in heart mitochondria. The catalase levels, either 
mRNA or protein, in the three tissue mitochondria were 
observed to be proportional to its abundance in the cyto-
plasm of the three tissues. The expression of catalase was 
found to be the lowest in both the cytoplasm and mitochon-
dria in all three tissues. Therefore, the organelle localization 
for catalase is likely to be dependent on the gene expression 
levels in the tissues or cells, and unlikely to be solely de-
pendent on the organelle favorability. HADHB has been 
recognized to form part of an enzyme complex called the 
mitochondrial trifunctional protein and participates in the 
breakdown of long-chain fatty acids in mitochondria [28]. 
Uchida et al. [29] pointed out that this protein is localized to 
the mitochondrial matrix. HADHB is expressed in many 
tissues such as liver, muscle and retina. In the results de-
scribed above, HADHB, either mRNA or protein, was de-
tected in all three tissues; however, the levels in the liver 
and heart tissue were higher than observed in the kidney. 
An important point is that HADHB was detected in the 
heart and liver mitochondria but not in the kidney mito-
chondria, whereas this protein is widely distributed in the 
cytoplasm of all three tissues. Moreover, HADHB mRNA 
and protein levels are not low in the kidney tissue and cyto-
plasm when compared with the other two tissues. Hence, 
this observation questions how the mitochondrial trifunc-
tional protein functions in kidney mitochondria, or the func-
tion of HADHB is not fully understood. SCOT is a mito-
chondrial matrix homodimer that was first identified in pig 
hearts and sheep kidneys [30,31]. SCOT catalyzes the re-
versible transfer of a CoA moiety from succinyl CoA to the 
ketone body acetoacetate [32]. The tissue levels of SCOT 
activity correlate well with the ketolytic capacity. The tran-
scriptomic and proteomic data above reveal that SCOT was 
undetectable in the liver, cell lysate or mitochondria. This 
observation is not unexpected because the liver normally 
lacks the enzymes that efficiently utilize ketone bodies, and 
synthesized ketone bodies in the liver diffuse into the blood 
where they are transported to other tissues for metabolism. 
SCOT in the heart and kidney mitochondria is thus capable 
of metabolizing ketone bodies in the circulatory system. 
In summary, we have integrated multiple approaches to 
systematically analyze proteins that are localized in particu-
lar cellular organelles, and based on the observations of this 
study propose the term tissue-specific mitochondrial pro-
teins. Although the mechanisms of how tissue-specific mi-
tochondrial proteins are generated have yet to be revealed, 
these proteins are likely to play an important role in diver-
sifying the functions of mitochondria located in different 
tissues. Understanding the tissue specific mitochondrial 
components will be important in fully understanding mito-
chondrial physiology and pathology. 
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Supplemental Figure 1  Confirmation of mitochondrial purity and integrity. A, Western blot was used to check the mitochondrial characterizations using 
antibodies of ATP synthase β, aldehyde dehydrogenase II, and Prohibitin as the mitochondrial biomarker, and antibodies of Aldehyde reductase and GAPDH 
as the cytoplasm biomarker. B, TEM images of mitochondrial preparations from liver, kidney and heart. The magnification of the TEM images was 20000x. 
The ratios of intact mitochondria were calculated the intact mitochondria number of the whole views in the three parallel preparations. And the intact mito- 
chondria percentage in liver, kidney and heart was depicted in the scale bar. 
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